CSMD3 and lung carcinoma: Our results indicated that these genes' (TP53, TTN, MUC16, RYR2, CSMD3, USH2A, LRP1B, ZFHX4, SYNE1, and XIRP2) mutations are frequently present in clinical lung cancer patients (Figure 4(a)).